1887

Abstract

The emergence of serotype 19A, following use of the heptavalent pneumococcal conjugate vaccine (PCV7), has been favoured by multiple antibiotic resistance of this serotype and by other unknown factors. The aim of this study was to examine 19A isolates from invasive pneumococcal diseases (IPD) obtained before and after PCV7 implementation to ascertain which characteristics, including the presence of pili, might have favoured the emergence of this serotype in Italy. All isolates from IPD collected at the Italian National Institute of Health in the years 2001–2003 and 2006–2009 were serotyped. The 19A isolates were submitted to antimicrobial susceptibility testing by Etest and were genotyped by a combination of pulsed field gel electrophoresis (PFGE) and Multi Locus Sequence Typing (MLST). The presence of the pilus islets PI-1 and PI-2 was detected by PCR assays targeting a marker gene in each islet. The proportion of 19A isolates from IPD significantly increased from 4 % in 2001–2003 to 12 % in 2006–2009. This was largely due to the expansion of a clone characterized by sequence type (ST) 416, clonal complex (CC) 199, already present in Italy before PCV7 implementation. This clone included isolates susceptible to penicillin and containing PI-1 genes. Other CCs contributed to the emergence of serotype 19A: CC63 and CC193, already present in 2001–2003, and new-emerging CCs or clones such as CC230, CC320 and ST5204, that include drug-resistant and/or pilus-positive isolates. The expansion of serotype 19A in Italy might have been favoured not only by antibiotic resistance, but also by other bacterial factors such as the presence of pili.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.061242-0
2013-08-01
2020-01-21
Loading full text...

Full text loading...

/deliver/fulltext/jmm/62/8/1220.html?itemId=/content/journal/jmm/10.1099/jmm.0.061242-0&mimeType=html&fmt=ahah

References

  1. Aguiar S. I., Serrano I., Pinto F. R., Melo-Cristino J., Ramirez M..Portuguese Surveillance Group for the Study of Respiratory Pathogens ( 2008a;). Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. . Clin Microbiol Infect 14:, 835–843. [CrossRef][PubMed]
    [Google Scholar]
  2. Aguiar S. I., Serrano I., Pinto F. R., Melo-Cristino J., Ramirez M.. ( 2008b;). The presence of the pilus locus is a clonal property among pneumococcal invasive isolates. . BMC Microbiol 8:, 41. [CrossRef][PubMed]
    [Google Scholar]
  3. Aguiar S. I., Pinto F. R., Nunes S., Serrano I., Melo-Cristino J., Sá-Leão R., Ramirez M., de Lencastre H.. ( 2010;). Denmark14-230 clone as an increasing cause of pneumococcal infection in Portugal within a background of diverse serotype 19A lineages. . J Clin Microbiol 48:, 101–108. [CrossRef][PubMed]
    [Google Scholar]
  4. Ansaldi F., Canepa P., de Florentiis D., Bandettini R., Durando P., Icardi G.. ( 2011;). Increasing incidence of Streptococcus pneumoniae serotype 19A and emergence of two vaccine escape recombinant ST695 strains in Liguria, Italy, 7 years after implementation of the 7-valent conjugated vaccine. . Clin Vaccine Immunol 18:, 343–345. [CrossRef][PubMed]
    [Google Scholar]
  5. Bagnoli F., Moschioni M., Donati C., Dimitrovska V., Ferlenghi I., Facciotti C., Muzzi A., Giusti F., Emolo C.. & other authors ( 2008;). A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cells. . J Bacteriol 190:, 5480–5492. [CrossRef][PubMed]
    [Google Scholar]
  6. Barocchi M. A., Ries J., Zogaj X., Hemsley C., Albiger B., Kanth A., Dahlberg S., Fernebro J., Moschioni M.. & other authors ( 2006;). A pneumococcal pilus influences virulence and host inflammatory responses. . Proc Natl Acad Sci U S A 103:, 2857–2862. [CrossRef][PubMed]
    [Google Scholar]
  7. Basset A., Trzcinski K., Hermos C., O’Brien K. L., Reid R., Santosham M., McAdam A. J., Lipsitch M., Malley R.. ( 2007;). Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence. . J Clin Microbiol 45:, 1684–1689. [CrossRef][PubMed]
    [Google Scholar]
  8. Beall B. W., Gertz R. E., Hulkower R. L., Whitney C. G., Moore M. R., Brueggemann A. B.. ( 2011;). Shifting genetic structure of invasive serotype 19A pneumococci in the United States. . J Infect Dis 203:, 1360–1368. [CrossRef][PubMed]
    [Google Scholar]
  9. Brueggemann A. B., Pai R., Crook D. W., Beall B.. ( 2007;). Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. . PLoS Pathog 3:, e168. [CrossRef][PubMed]
    [Google Scholar]
  10. Choi E. H., Kim S. H., Eun B. W., Kim S. J., Kim N. H., Lee J., Lee H. J.. ( 2008;). Streptococcus pneumoniae serotype 19A in children, South Korea. . Emerg Infect Dis 14:, 275–281. [CrossRef][PubMed]
    [Google Scholar]
  11. Del Grosso M., Northwood J. G., Farrell D. J., Pantosti A.. ( 2007;). The macrolide resistance genes erm(B) and mef(E) are carried by Tn2010 in dual-gene Streptococcus pneumoniae isolates belonging to clonal complex CC271. . Antimicrob Agents Chemother 51:, 4184–4186. [CrossRef][PubMed]
    [Google Scholar]
  12. European Committee on Antimicrobial Susceptibility Testing ( 2013;). Breakpoint tables for interpretation of MICs and zone diameters. . http://www.eucast.org/clinical_breakpoints/.
  13. Fenoll A., Granizo J. J., Aguilar L., Giménez M. J., Aragoneses-Fenoll L., Hanquet G., Casal J., Tarragó D.. ( 2009;). Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. . J Clin Microbiol 47:, 1012–1020. [CrossRef][PubMed]
    [Google Scholar]
  14. Gherardi G., Fallico L., Del Grosso M., Bonanni F., D’Ambrosio F., Manganelli R., Palù G., Dicuonzo G., Pantosti A.. ( 2007;). Antibiotic-resistant invasive pneumococcal clones in Italy. . J Clin Microbiol 45:, 306–312. [CrossRef][PubMed]
    [Google Scholar]
  15. Gherardi G., D'Ambrosio F., Visaggio D., Dicuonzo G., Del Grosso M., Pantosti A.. ( 2012;). Serotype and clonal evolution of penicillin-nonsusceptible invasive Streptococcus pneumoniae in the 7-valent pneumococcal conjugate vaccine PCV7 era in Italy. . Antimicrob Agents Chemother 56:, 4965–4968. [CrossRef][PubMed]
    [Google Scholar]
  16. Gianfaldoni C., Censini S., Hilleringmann M., Moschioni M., Facciotti C., Pansegrau W., Masignani V., Covacci A., Rappuoli R.. & other authors ( 2007;). Streptococcus pneumoniae pilus subunits protect mice against lethal challenge. . Infect Immun 75:, 1059–1062. [CrossRef][PubMed]
    [Google Scholar]
  17. Hausdorff W. P., Bryant J., Paradiso P. R., Siber G. R.. ( 2000;). Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. . Clin Infect Dis 30:, 100–121. [CrossRef][PubMed]
    [Google Scholar]
  18. Hsu H. E., Shutt K. A., Moore M. R., Beall B. W., Bennett N. M., Craig A. S., Farley M. M., Jorgensen J. H., Lexau C. A.. & other authors ( 2009;). Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. . N Engl J Med 360:, 244–256. [CrossRef][PubMed]
    [Google Scholar]
  19. ICONA Working Group ( 2009;) ICONA 2008: national vaccination coverage survey among children and adolescents. . viii:118 Rapporti ISTISAN 09/29 (in Italian). http://www.iss.it/binary/publ/cont/09_29_web.pdf
  20. Kreikemeyer B., Gámez G., Margarit I., Giard J. C., Hammerschmidt S., Hartke A., Podbielski A.. ( 2011;). Genomic organization, structure, regulation and pathogenic role of pilus constituents in major pathogenic Streptococci and Enterococci.. Int J Med Microbiol 301:, 240–251. [CrossRef][PubMed]
    [Google Scholar]
  21. Lepoutre A., Varon E., Georges S., Gutmann L., Lévy-Bruhl D.. ( 2008;). Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001–2006. . Euro Surveill 13:, 18962.[PubMed]
    [Google Scholar]
  22. Mahjoub-Messai F., Doit C., Koeck J. L., Billard T., Evrard B., Bidet P., Hubans C., Raymond J., Levy C.. & other authors ( 2009;). Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after introduction of seven-valent pneumococcal vaccination for French children. . J Clin Microbiol 47:, 837–840. [CrossRef][PubMed]
    [Google Scholar]
  23. Marimón J. M., Alonso M., Rolo D., Ardanuy C., Liñares J., Pérez-Trallero E.. ( 2012;). Molecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions (1994–2009). . Eur J Clin Microbiol Infect Dis 31:, 10096–10013. [CrossRef][PubMed]
    [Google Scholar]
  24. Miller E., Andrews N. J., Waight P. A., Slack M. P., George R. C.. ( 2011;). Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. . Lancet Infect Dis 11:, 760–768. [CrossRef][PubMed]
    [Google Scholar]
  25. Monaco M., Camilli R., D’Ambrosio F., Del Grosso M., Pantosti A.. ( 2005;). Evolution of erythromycin resistance in Streptococcus pneumoniae in Italy. . J Antimicrob Chemother 55:, 256–259. [CrossRef][PubMed]
    [Google Scholar]
  26. Moschioni M., Donati C., Muzzi A., Masignani V., Censini S., Hanage W. P., Bishop C. J., Reis J. N., Normark S.. & other authors ( 2008;). Streptococcus pneumoniae contains 3 rlrA pilus variants that are clonally related. . J Infect Dis 197:, 888–896. [CrossRef][PubMed]
    [Google Scholar]
  27. Muñoz-Almagro C., Jordan I., Gene A., Latorre C., Garcia-Garcia J. J., Pallares R.. ( 2008;). Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. . Clin Infect Dis 46:, 174–182. [CrossRef][PubMed]
    [Google Scholar]
  28. Nelson A. L., Ries J., Bagnoli F., Dahlberg S., Fälker S., Rounioja S., Tschöp J., Morfeldt E., Ferlenghi I.. & other authors ( 2007;). RrgA is a pilus-associated adhesin in Streptococcus pneumoniae.. Mol Microbiol 66:, 329–340. [CrossRef][PubMed]
    [Google Scholar]
  29. Pilishvili T., Lexau C., Farley M. M., Hadler J., Harrison L. H., Bennett N. M., Reingold A., Thomas A., Schaffner W.. & other authors ( 2010;). Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. . J Infect Dis 201:, 32–41. [CrossRef][PubMed]
    [Google Scholar]
  30. Pillai D. R., Shahinas D., Buzina A., Pollock R. A., Lau R., Khairnar K., Wong A., Farrell D. J., Green K.. & other authors ( 2009;). Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae.. BMC Genomics 10:, 642. [CrossRef][PubMed]
    [Google Scholar]
  31. Regev-Yochay G., Hanage W. P., Trzcinski K., Rifas-Shiman S. L., Lee G., Bessolo A., Huang S. S., Pelton S. I., McAdam A. J.. & other authors ( 2010;). Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. . Vaccine 28:, 4842–4846. [CrossRef][PubMed]
    [Google Scholar]
  32. Reinert R., Jacobs M. R., Kaplan S. L.. ( 2010;). Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. . Vaccine 28:, 4249–4259. [CrossRef][PubMed]
    [Google Scholar]
  33. Selva L., Ciruela P., Blanchette K., del Amo E., Pallares R., Orihuela C. J., Muñoz-Almagro C.. ( 2012;). Prevalence and clonal distribution of pcpA, psrP and Pilus-1 among pediatric isolates of Streptococcus pneumoniae.. PLoS ONE 7:, e41587. [CrossRef][PubMed]
    [Google Scholar]
  34. van der Linden M., Reinert R. R., Kern W. V., Imöhl M.. ( 2013;). Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children. . BMC Infect Dis 13:, 70. [CrossRef][PubMed]
    [Google Scholar]
  35. Whitney C. G., Farley M. M., Hadler J., Harrison L. H., Bennett N. M., Lynfield R., Reingold A., Cieslak P. R., Pilishvili T.. & other authors ( 2003;). Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. . N Engl J Med 348:, 1737–1746. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.061242-0
Loading
/content/journal/jmm/10.1099/jmm.0.061242-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error